Key regions: Japan, India, Italy, Brazil, South Korea
The demand for Anti-Hypertensive Drugs in Tajikistan is experiencing steady growth over the years.
Customer preferences: The increasing prevalence of hypertension in the country is the primary factor driving the demand for Anti-Hypertensive Drugs. According to the World Health Organization, hypertension is a significant health problem in Tajikistan, with a prevalence rate of over 25%. This high prevalence rate is attributed to a combination of factors such as poor diet, lack of physical activity, and genetic predisposition. As a result, there is a growing need for effective medications to manage hypertension and reduce the risk of cardiovascular diseases.
Trends in the market: The Anti-Hypertensive Drugs market in Tajikistan is witnessing a shift towards generic drugs due to their affordability and availability. The high cost of branded drugs is a major barrier to access for many patients in the country, especially those from low-income households. As a result, many patients are turning to generic drugs, which are more affordable and readily available in the market. The government's efforts to promote the use of generic drugs have also contributed to this trend.
Local special circumstances: The healthcare system in Tajikistan is underdeveloped, and access to quality healthcare services is limited, particularly in rural areas. As a result, patients with hypertension often face challenges in accessing healthcare services and medications. The government has implemented several initiatives to improve access to healthcare services in the country, including the provision of free basic healthcare services to the population. However, the quality of healthcare services remains a significant challenge.
Underlying macroeconomic factors: Tajikistan's economy is heavily dependent on remittances from migrant workers, which account for over 30% of the country's GDP. The COVID-19 pandemic has had a significant impact on the economy, leading to a decline in remittances and a slowdown in economic growth. The pandemic has also disrupted global supply chains, leading to shortages of essential medicines, including Anti-Hypertensive Drugs. The government has taken steps to mitigate the impact of the pandemic on the healthcare system, including increasing domestic production of essential medicines. However, the long-term impact of the pandemic on the Anti-Hypertensive Drugs market in Tajikistan remains uncertain.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
